Judgment of the Court (First Chamber) of 21 November 2018

Novartis Farma SpA v Agenzia Italiana del Farmaco (AIFA) and Others

Request for a preliminary ruling from the Consiglio di Stato

Reference for a preliminary ruling — Medicinal products for human use — Directive 2001/83/EC — Article 3(1) — Article 6 — Directive 89/105/EEC — Regulation (EC) No 726/2004 — Articles 3, 25 and 26 — Repackaging of a medicinal product for use as a treatment not covered by its marketing authorisation (off-label use) — Reimbursement by the national healthcare insurance system

Case C-29/17


Top of the page Documents in the Case
Document Date Name of the parties Subject-matter Curia EUR-Lex Autres Liens
Judgment (OJ)
04/01/2019 Novartis Farma
Judgment
ECLI:EU:C:2018:931
21/11/2018 Novartis Farma
Judgment (Summary)
ECLI:EU:C:2018:931
21/11/2018 Novartis Farma
Application (OJ)
02/06/2017 Novartis Farma
Opinion
ECLI:EU:C:2018:619
25/07/2018 Novartis Farma
Top of the page Legal analysis of the decision or of the case

Reports of Cases

published in the electronic Reports of Cases (Court Reports - general)

Subject-matter

Information not available

Systematic classification scheme

1.
1 The legal order of the European Union
  1.03 Respective powers and obligations of the European Union and of the Member States
    1.03.01 Conferring of powers
4 Internal policy of the European Union
  4.11 Approximation of laws
    4.11.14 Pharmaceutical and cosmetic products
      4.11.14.01 Medicinal products for human use
        4.11.14.01.01 Scope of the legislation
4 Internal policy of the European Union
  4.11 Approximation of laws
    4.11.14 Pharmaceutical and cosmetic products
      4.11.14.01 Medicinal products for human use
        4.11.14.01.04 Marketing authorisation
          4.11.14.01.04.01 Obligation to obtain
2 Institutional framework of the European Union
  2.02 Other EU bodies and agencies
    2.02.07 Agencies, offices and foundations


Citations of case-law or legislation

References in grounds of judgment

Operative part

Opinion


Dates

Date of the lodging of the application initiating proceedings

  • 19/01/2017

Date of the Opinion

  • 25/07/2018

Date of the hearing

Information not available

Date of delivery

21/11/2018


References

Publication in the Official Journal

Judgment: OJ C 25 from 21.01.2019, p.4

Application: OJ C 195 from 19.06.2017, p.9

Name of the parties

Novartis Farma

Notes on Academic Writings

  1. Simon, Denys: Médicaments, Europe 2019 Janvier Comm. nº 1 p.45 (FR)
  2. Mignolet, Olivier ; Murovec, Vladimir: Arrêt "Novartis Farma" : la Cour précise les règles de commercialisation des médicaments prescrits hors indication (off-label), Journal de droit européen 2019 nº 259 p.202-203 (FR)
  3. Parziale, Andrea: Rimborsabilità degli usi off-label di medicinali: via libera della Corte di giustizia, Il Foro italiano 2019 N°2 Parte IV Col.115-120 (IT)
  4. Raposo, Vera Lúcia: The CJEU’s ruling in the Novartis Farma case: money, health and medicines, Maastricht Journal of European and Comparative Law 2020 p. 178-198 (EN)



Procedural Analysis Information

Source of the question referred for a preliminary ruling

Consiglio di Stato - Italy

Subject-matter

  • Approximation of laws

Provisions of national law referred to

Information not available

Provisions of international law referred to

Information not available

Procedure and result

  • Reference for a preliminary ruling
  • Reference for a preliminary ruling : case not proceeding to judgment

Formation of the Court

Information not available

Judge-Rapporteur

Fernlund

Advocate General

Information not available

Language(s) of the Case

  • Italian

Language(s) of the Opinion

    Information not available